TARDBP and amyotrophic lateral sclerosis: The levels of both TDP-43 species in the insoluble fractions were increased in response to ALS-CSF, whereas IMS-088 treatment reduced levels of insoluble TDP-43 to those found in NALS group (Figure 3C).